Brief: Athira Pharma Q2 Operating Expenses USD 28.028 Million

Aug 01 (Reuters) - Athira Pharma Q2 operating income USD -28.028 million.
* Q2 net income USD -26.859 million

Recent news on LeonaBio

See all news